Skip to content
★ Sign in to follow
PS
Total declarations
39
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (12 ops.)
€11.2M

Latest filing published 01 Mar 2021 for ChemoCentryx, Inc., €12k.

Filing timeline

BuySale
Pui San Kwan

Insider track record

Disclosed buys
0
Disclosed sells
12
Signal history

Pui San Kwan: trading record in brief

This profile gathers the share dealings of Pui San Kwan in ChemoCentryx, Inc. We count 39 filings; the first trade dates from 6 January 2020 and the latest from 1 March 2021.

The open-market record consists of 12 sales worth €11.2M, with no purchase. The rest of the record consists of 27 option exercises. In 2021 alone, the filings show no purchases and 4 sales.

The newest entry dates from 1 March 2021: an open-market sale of €104k, in ChemoCentryx, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Pui San Kwan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations39 total
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    15,085 USD11SEC
    1,389 shares@ US$10.860.1% of flowCommon StockSEC:0001209191-21-015496:0
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    12,398 USD11SEC
    1,125 shares@ US$11.020.1% of flowCommon StockSEC:0001209191-21-015496:1
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    7,530 USD11SEC
    833 shares@ US$9.040.0% of flowCommon StockSEC:0001209191-21-015496:2
  • ▼
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    104,162 USD26SEC
    1,530 shares@ US$68.080.7% of flowCommon StockSEC:0001209191-21-015496:3
  • ▼
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    125,173 USD26SEC
    1,817 shares@ US$68.890.8% of flowCommon StockSEC:0001209191-21-015496:4
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    15,085 USD11SEC
    1,389 shares@ US$10.860.1% of flowCommon StockSEC:0001209191-21-008638:0
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    12,398 USD11SEC
    1,125 shares@ US$11.020.1% of flowCommon StockSEC:0001209191-21-008638:1
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    7,530 USD11SEC
    833 shares@ US$9.040.0% of flowCommon StockSEC:0001209191-21-008638:2
  • ▼
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    217,555 USD26SEC
    3,347 shares@ US$65.001.4% of flowCommon StockSEC:0001209191-21-008638:3
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    5,521 USD11SEC
    834 shares@ US$6.620.0% of flowCommon StockSEC:0001209191-21-005758:0
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    15,106 USD11SEC
    1,391 shares@ US$10.860.1% of flowCommon StockSEC:0001209191-21-005758:1
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    12,398 USD11SEC
    1,125 shares@ US$11.020.1% of flowCommon StockSEC:0001209191-21-005758:2
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    7,539 USD11SEC
    834 shares@ US$9.040.0% of flowCommon StockSEC:0001209191-21-005758:3
  • ▼
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    271,960 USD26SEC
    4,184 shares@ US$65.001.7% of flowCommon StockSEC:0001209191-21-005758:4
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    2,977 USD11SEC
    834 shares@ US$3.570.0% of flowCommon StockSEC:0001209191-20-063915:0
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    44,136 USD11SEC
    6,667 shares@ US$6.620.3% of flowCommon StockSEC:0001209191-20-063915:1
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    16,045 USD11SEC
    1,456 shares@ US$11.020.1% of flowCommon StockSEC:0001209191-20-063915:2
  • ▼
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    582,398 USD23SEC
    8,957 shares@ US$65.02153.8% of flowCommon StockSEC:0001209191-20-063915:3
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    22,064 USD11SEC
    3,333 shares@ US$6.620.1% of flowCommon StockSEC:0001209191-20-063915:4
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    120,327 USD11SEC
    10,919 shares@ US$11.020.8% of flowCommon StockSEC:0001209191-20-063915:5
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    181,091 USD11SEC
    16,675 shares@ US$10.861.2% of flowCommon StockSEC:0001209191-20-063915:6
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    105,461 USD11SEC
    11,666 shares@ US$9.040.7% of flowCommon StockSEC:0001209191-20-063915:7
  • ▼
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    3M USD25SEC
    42,593 shares@ US$65.063218.2% of flowCommon StockSEC:0001209191-20-063915:8
  • ▼
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    930,950 USD30SEC
    18,941 shares@ US$49.156.8% of flowCommon StockSEC:0001209191-20-009442:0
  • ◇
    Principal Acctg OfficerExecutivesChemoCentryx, Inc.
    51,958 USD11SEC
    14,554 shares@ US$3.570.4% of flowCommon StockSEC:0001209191-20-004167:0

25 of 39 declarations